SCHEMBL4493683

SCHEMBL4493683

CN(C)CCCNC(=O)N(C)c1ccc(NC(=C2C(=O)Nc3cc(Cl)ccc32)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
TERT O14746 2/20 0.38
PLK1 P53350 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
MBTD1 Q05BQ5 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CHEK1 O14757 1/20 0.35
DAPK3 O43293 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
PAK4 O96013 1/20 0.35
ABL1 P00519 1/20 0.35
LCK P06239 1/20 0.35
RET P07949 1/20 0.35
MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4493678 1.00 ALDH1A1 (0.39) ALDH1A1KDM4ETERTPLK1MEN1
SCHEMBL4492087 0.90 PRKAA1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4492092 0.90 PRKAA1 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4485365 0.89 NAMPT (0.46) ALDH1A1KDM4ETERTMEN1KMT2A
SCHEMBL4485359 0.89 NAMPT (0.46) ALDH1A1KDM4ETERTMEN1KMT2A
SCHEMBL4491612 0.89 PLK1 (0.38) ALDH1A1KDM4ETERTPLK1TMEM97
SCHEMBL4491607 0.89 PLK1 (0.38) ALDH1A1KDM4ETERTPLK1TMEM97
SCHEMBL2567931 0.89 SENP1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL2567933 0.89 SENP1 (0.43) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4495867 0.88 PLK1 (0.37) ALDH1A1KDM4ETERTPLK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR ALDH1A1 2036/4885KDM4E 1648/4885TERT 1909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.